|
|
|
|
High Efficacy of
Sofosbuvir/Velpatasvir/GS-9857
With or Without Ribavirin for 12 Weeks in Direct-Acting Antiviral-Experienced Patients With Genotype 1 HCV Infection
|
|
|
from Jules: these are patients with prior DAA experience: NS5A, protease, NS5B...48/49 had SVR....1 relapse
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Eric Lawitz1, Fred Poordad1, Jennifer Wells1, Robert H. Hyland2, Yin Yang2, Hadas Dvory-Sobol2, Luisa M. Stamm2, Diana M. Brainard2,
John G. McHutchison2, Carmen Landaverde1, Julio Gutierrez1
1Texas Liver Institute, University of Texas Health Science Center, San Antonio, Texas, USA; 2Gilead Sciences, Inc., Foster City, California, USA
|
|
|
|
|
|
|